// App-Quantinova.ai

Filters

Biomarkers











Conference Name











Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























169 Abstracts

Cystatin C decreases proliferation of melanoma cells by affecting mitosis length

Hanna Wallin - American Association for Cancer Research (AACR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Cysteine Hydrochloride

HIGH RESOLUTION MASS SPECTROMETRY PARALLEL REACTION MONITORING MULTIPLEX ASSAYS OF HUMAN CSF PROTEINS USING MINIMUM SAMPLE PREPARATION

Gunnar Brinkmalm - Alzheimer's Association International Conference (AAIC) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Trypsin

A NOVEL CSF 16PLEX NEURODEGENERATION ASSAY

Christopher Loener - Alzheimer's Association International Conference (AAIC) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Fibrinogen (IV)

Estimation of Glomerular Filtration Rate (GFR) Using Serum Cystatin C and Creatinine Has Poor Precision and Accuracy in Adults with HbSS Sickle Cell Disease

Marianne E. Yee - American Society of Hematology (ASH) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Sickle cell anemia

Hydroxyurea

Increased serum cystatin C level is significantly associated with uncontrolled blood pressure in hypertensive patients with normal kidney functions

Sadi Gulec - American Society of Hypertension (ASHy) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hypertension

N/A

Estimation of GFR (eGFR) in Preterm Infants (<31 Wks) by Using Serum Creatinine and Cystatin C

Parvesh Mohan Garg - Pediatric Academic Societies (PAS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparison of Urinary Neutrophil Gelatinase-Associated Lipocalin(NGAL) and Serum Cystatin C for Early Detection of Acute Kidney Injury in Very Low Birth Weight Infants

So Young Shin - Pediatric Academic Societies (PAS) , 2016

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Patent ductus arteriosus

N/A

Cystatin C Is a Marker for Both Inflammation and Renal Function in HIV+ Children

Angela Deya-Martinez - Conference on Retroviruses and Opportunistic Infections (CROI) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Ergocalciferol

Cystatin C Is Associated With Neurocognitive Impairment in Older HIV+ Adults

Marissa Sakoda - Conference on Retroviruses and Opportunistic Infections (CROI) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Characterization of Neonatal Proteinuria in Term and Preterm Infants: Baseline for a Prospective Clinical Trial

Wacharee Seeherunvong - Pediatric Academic Societies (PAS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Acute renal failure

N/A

Mapping Baseline Urinary Biomarkers Among Healthy Neonates Across Gestational Age Groups

Marissa DeFreitas - Pediatric Academic Societies (PAS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Acute renal failure

N/A

Evolution of Renal Function in Preterm Less Than 1500 gr from Birth To Second Year of Life By Creatinine and Cystatin C

Marta Cabrera - Pediatric Academic Societies (PAS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Does Weight Misperception Have Protective Effects in Sexual Minorities? The Relationship Between Sexual Orientation, Weight Misperception, and Depressive Symptoms Among Overweight/Obese Youth

Bradford Nguyen - Pediatric Academic Societies (PAS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Pain (neuropathic)

Cysteine Hydrochloride

Estimation of Glomerular Filtration Rate With Serum Cystatin C Accurately Discriminates Renal Dysfunction in Liver Transplant Candidates With End-Stage Liver Disease

S. Gonzalez - American Transplant Congress (ATC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Nephrology

End-stage liver disease

Glofil-125

Renal Tubular Dysfunction Following Donor Nephrectomy and Its Impact On Residual Kidney Function

Z. Ahmed - American Transplant Congress (ATC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Cytomegalovirus infection

Methadone hydrochloride

MDRD4 Equation Is Better Than CKD-EPI, Cockroft-Gault and Nankivell Equations to Estimate Glomerular Filtration Rate in Renal Transplantation

E. David-Neto - American Transplant Congress (ATC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Chronic kidney disease

Methadone hydrochloride

THE ROLE OF THE AMYLOID PRECURSOR PROTEIN IN NEURAL STEM CELL PROLIFERATION AND DIFFERENTIATION

D.H. Small - International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PDTM) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Cystatin C is associated with neurocognitive impairment in older HIV+ adults

Marissa Sakoda - American Academy of Neurology (AAN) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Estimation of GFR (eGFR) in Preterm Infants (<31 Wks) by Using Serum Creatinine and Cystatin C

Parvesh Mohan Garg - Pediatric Academic Societies (PAS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Biomarkers in Lupus Nephritis: The Possible Role of Serum Cystatin C, Serum beta2-Microglobulin, Urinary I+-1-Microglobulin and Albumina Creatinine Ratio

Luca Petricca - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus nephritis

N/A

Copyright © 2026. QuantiNova All rights reserved